Chitosan nanoparticles as delivery systems for doxorubicin

Journal of Controlled Release

Volumn 73, Issue 2-3, 2001, Pages 255-267

  Janes, Kevin A ^a   Fresneau, Marie P ^a   Marazuela, Ana ^b   Fabra, Angels ^b   Alonso, María José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

Adriamycin; Chitosan; Dextran sulfate; Doxorubicin; Nanoparticles

Indexed keywords

ANTHRACYCLINE; CHITOSAN; DEXTRAN SULFATE; DOXORUBICIN; DRUG CARRIER; NANOPARTICLE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSTASIS; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; FLUOROMETRY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CHITIN; CHITOSAN; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0035850215     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00294-2     Document Type: Article

References (32)

1. Expression of multidrug resistance gene in human cancers
2. The cardiotoxicity of anticancer agents
3. Synthesis, characterization and antitumor activity of macromolecular prodrugs of adriamycin
4. Microparticulate drug delivery systems as an adjunct to cancer treatment
5. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin
6. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times
7. Nanoparticles as microcarriers for anticancer drugs
8. Physical entrapment of adriamycin in AB block copolymer micelles
9. Hydrogel nanoparticle formed by self-assembly of hydrophobized polysaccharide. Stabilization of adriamycin by complexation
10. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release
11. Clinical phamacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracycline
12. Development of a nanoparticle controlled-release formulation for human use
13. Toxicity of polyalkylcyanoacrylate nanoparticles. II. Doxorubicin loaded nanoparticles
14. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
15. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles
16. Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles
17. Enhanced transport of nanoparticle associated drugs through natural and artificial membranes - A general phenomena?
18. Biocompatibility of chitosan by oral and intravenous administration
19. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)
20. Enhancement of nasal absorption of insulin using chitosan nanoparticles
21. In vitro degradation rates of partially N-acetylated chitosans in human serum
22. In vitro approaches for determining mechanisms of toxicity and carcinogenicity by asbestos in the gastrointestinal and respiratory tracts
23. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
24. Hydrogen ion titration of chitosans with varying degrees of N-acetylation by monitoring induced H-NMR chemical shifts
25. Electronic absorption spectra and protolytic equilibria of doxorubicin: Direct spectrophotometric determination of microconstants
26. Evaluation of ion-exchange microspheres as carriers for the anticancer drug doxorubicin: In vitro studies
27. Synthesis of albumin-dextran sulfate microspheres possessing favorable loading and release characteristics for the anticancer drug doxorubicin
28. Iron(III)-adriamycin and iron(III)-daunorubicin complexes: Physiochemical characteristics, interaction with DNA and antitumor activity
29. EPR studies of copper(III) and cobalt(II) complexes of adriamycin
30. Deciphering the fluorescence signature of daunomycin and doxorubicin